Source 1primary paper2025MED
Toolkit/chemiluminescent enzyme immunoassay
chemiluminescent enzyme immunoassay
Also known as: CLEIA
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Classical immunoassays such as enzyme-linked immunosorbent assay (ELISA), chemiluminescent enzyme immunoassay (CLEIA), and single molecule array (SIMOA) remain central to fluid based detection, offering high sensitivity and clinical validation.
Usefulness & Problems
Why this is useful
CLEIA is described as a classical immunoassay used for fluid-based p-Tau detection. It is grouped with established benchmark assays.; fluid-based detection of hyperphosphorylated Tau
Source:
CLEIA is described as a classical immunoassay used for fluid-based p-Tau detection. It is grouped with established benchmark assays.
Source:
fluid-based detection of hyperphosphorylated Tau
Problem solved
It enables sensitive and clinically validated measurement of p-Tau in biofluids.; provides clinically validated p-Tau detection in fluids
Source:
It enables sensitive and clinically validated measurement of p-Tau in biofluids.
Source:
provides clinically validated p-Tau detection in fluids
Problem links
provides clinically validated p-Tau detection in fluids
LiteratureIt enables sensitive and clinically validated measurement of p-Tau in biofluids.
Source:
It enables sensitive and clinically validated measurement of p-Tau in biofluids.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Techniques
Functional AssayTarget processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The abstract indicates a chemiluminescent immunoassay format for fluid samples, but does not provide further implementation details.; requires immunoassay format for fluid-based detection
Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. No canonical validation observations are stored yet, so context-specific performance remains under-specified.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
ELISA, CLEIA, and SIMOA remain central to fluid-based p-Tau detection and offer high sensitivity and clinical validation.
Approval Evidence
1 source1 linked approval claimfirst-pass slug chemiluminescent-enzyme-immunoassay
Classical immunoassays such as enzyme-linked immunosorbent assay (ELISA), chemiluminescent enzyme immunoassay (CLEIA), and single molecule array (SIMOA) remain central to fluid based detection, offering high sensitivity and clinical validation.
Source:
assay utilitysupports
ELISA, CLEIA, and SIMOA remain central to fluid-based p-Tau detection and offer high sensitivity and clinical validation.
Source:
Comparisons
Source-stated alternatives
The abstract places CLEIA alongside ELISA and SIMOA, and contrasts these with next-generation biosensor platforms.
Source:
The abstract places CLEIA alongside ELISA and SIMOA, and contrasts these with next-generation biosensor platforms.
Source-backed strengths
high sensitivity; clinical validation
Source:
high sensitivity
Source:
clinical validation
Compared with enzyme-linked immunosorbent assay
The abstract places CLEIA alongside ELISA and SIMOA, and contrasts these with next-generation biosensor platforms.
Shared frame: source-stated alternative in extracted literature
Strengths here: high sensitivity; clinical validation.
Source:
The abstract places CLEIA alongside ELISA and SIMOA, and contrasts these with next-generation biosensor platforms.
Compared with single molecule array
The abstract places CLEIA alongside ELISA and SIMOA, and contrasts these with next-generation biosensor platforms.
Shared frame: source-stated alternative in extracted literature
Strengths here: high sensitivity; clinical validation.
Source:
The abstract places CLEIA alongside ELISA and SIMOA, and contrasts these with next-generation biosensor platforms.
Ranked Citations
- 1.